No.93 December 5, 2011

Drug cost ratio
National healthcare expenditure
Wards for recuperation under health insurance
Wards for recuperation under nursing care insurance
Ward charging special admission fee
Ward for rehabilitation during convalescence

The drug cost ratio (薬剤費比率) is defined as the cost of drugs (薬剤費) used under the health insurance system (医療保険制度) as a percentage of national healthcare expenditure (国民医療費). As a rule, each ethical drug (医療用医薬品) is reimbursed at its NHI...

To read the full story


By Izuru Ando

While Japan has now granted its first emergency approval to Shionogi’s COVID-19 pill Xocova (ensitrelvir), the drug failed to win a unanimous vote by advisory panels, with skepticism lingering over its actual efficacy. To prep for the next emergency, which…

By Philip Carrigan

As the year 2022 draws to a close, what are managers thinking at the world’s leading pharmaceutical companies and medical device companies? We surveyed 86 managers at these companies to find out what’s on their minds.For many managers, a common…

A Japanese reimbursement policy panel on November 16 saw a continued scuffle between members representing healthcare providers and payers over…

Deloitte Tohmatsu Consulting proposed three drug pricing schemes designed to trigger the consolidation of generic makers on October 27, offering…

Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…

Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…